Elucidation of detailed molecular interactions with the actin cytoskeleton and the involved binding partners of pJNK and MAPKBP1 as well as investigation of the JNK signaling pathway in the pathophysiology of other NPHPs could lead to the identification of promising targets for the development of specific treatment strategies for patients with NPH. Here, MAPKBP1 is linked to normal pressure hydrocephalus.